Please try another search
LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm specializing in neurogenetic medicines, announced today that it has licensed a novel capsid from its proprietary...
“ Collaboration combines Dren's targeted cell depletion platform with Novartis (LON:0QLR) research, development and commercial expertise to advance innovative therapies for cancer ““ Dren Bio to...
CARLSBAD, Calif., May 31, 2024 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical...
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical...
Continuous Kesimpta ® treatment for up to six years showed sustained efficacy in recently diagnosed ( ‰¤3 years) treatment-naïve people living with relapsing multiple...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review